NCT07021911View on ClinicalTrials.gov

Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

May 17, 2029

Study Completion Date

May 17, 2029

Conditions
Breast CancerRadiotherapy; Complications
Interventions
RADIATION

Radiotherapy

Conventional fractionated radiotherapy, moderate hypofractionated radiotherapy, stereotactic radiotherapy (SABR)

Trial Locations (1)

00128

RECRUITING

Radiation Oncology Department Fondazione Policlinico Campus BioMedico, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER